back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-12-13 14:54 Tx date 2023-12-08 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+93,800 vol |
174,500 | |
| Filed 2023-12-13 14:52 Tx date 2023-12-08 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$668,500
+350,000 vol $1.91 each |
1,855,631 | |
| Filed 2023-11-20 09:36 Tx date 2023-11-19 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-150,000 vol |
1,505,631 | |
| Filed 2023-08-18 11:57 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+80,700 vol |
80,700 | |
| Filed 2023-08-18 11:38 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$830,759
+301,000 vol $2.76 each |
1,655,631 | |
| Filed 2022-12-19 10:44 Tx date 2022-12-17 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-13,157 vol |
1,354,631 | |
| Filed 2022-12-13 12:49 Tx date 2022-12-09 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$231,000
+100,000 vol $2.31 each |
1,367,788 | |
| Filed 2022-06-15 14:59 Tx date 2022-06-15 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,669
+7,900 vol $0.84 each |
96,333 | |
| Filed 2022-06-14 15:15 Tx date 2022-06-14 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,821
+5,774 vol $0.83 each |
88,433 | |
| Filed 2022-03-09 10:11 Tx date 2022-03-08 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-988,412.49
-133,389 vol $7.41 each |
1,267,788 | |
| Filed 2021-12-15 09:46 Tx date 2021-12-14 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-13,157 vol |
1,401,177 | |
| Filed 2021-12-13 17:32 Tx date 2021-12-10 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$135,200
+65,000 vol $2.08 each |
1,414,334 | |
| Filed 2021-07-28 10:36 Tx date 2021-07-27 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-77,559.30
-1,894 vol $40.95 each |
1,349,334 | |
| Filed 2021-03-12 19:12 Tx date 2021-03-12 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+34,736 vol |
82,659 | |
| Filed 2021-03-12 19:10 Tx date 2021-03-12 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
57 - Exercise of rights
|
-34,736 vol |
0 | |
| Filed 2021-03-12 18:06 Tx date 2021-03-08 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,428,000
+420,000 vol $3.40 each |
1,351,228 | |
| Filed 2021-02-14 16:34 Tx date 2020-12-14 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-772,783.20
-12,105 vol $63.84 each |
931,228 | |
| Filed 2020-12-15 10:11 Tx date 2020-12-14 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-772,783.20
-12,105 vol $63.84 each |
||
| Filed 2020-12-16 16:55 Tx date 2020-12-11 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$951,000
+300,000 vol $3.17 each |
943,333 | |
| Filed 2020-12-15 10:11 Tx date 2020-12-14 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-772,783.20
-12,105 vol $63.84 each |
631,228 | |
| Filed 2020-03-09 10:20 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$253,750
+175,000 vol $1.45 each |
643,333 | |
| Filed 2019-12-18 15:32 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$253,750
+175,000 vol $1.45 each |
||
| Filed 2019-12-18 15:32 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$253,750
+175,000 vol $1.45 each |
643,333 | |
| Filed 2019-12-09 10:21 Tx date 2019-12-08 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-91,773.99
-3,157 vol $29.07 each |
468,333 | |
| Filed 2019-10-02 15:08 Tx date 2019-10-02 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,270
+10,000 vol $0.427 each |
47,923 | |
| Filed 2019-06-18 16:36 Tx date 2019-06-18 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,951
+1,300 vol $2.27 each |
37,923 | |
| Filed 2019-01-28 Tx date 2018-12-21 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,775
+12,500 vol $1.74 each |
||
| Filed 2019-01-28 Tx date 2018-12-21 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
$2,158
+1,250 vol $1.73 each |
36,623 | |
| Filed 2018-12-22 Tx date 2018-12-21 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,775
+12,500 vol $1.74 each |
47,873 | |
| Filed 2018-12-12 Tx date 2018-12-11 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,145
+5,000 vol $2.03 each |
35,373 | |
| Filed 2018-11-23 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
37 - Stock split or consolidation
|
-295,264 vol |
34,736 | |
| Filed 2018-11-23 Tx date 2018-11-19 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$516,000
+150,000 vol $3.44 each |
471,490 | |
| Filed 2018-11-23 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-258,177 vol |
30,373 | |
| Filed 2018-11-23 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-2,732,710 vol |
321,490 | |
| Filed 2018-03-16 Tx date 2018-03-15 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$988,416
+1,267,200 vol $0.78 each |
3,054,200 | |
| Filed 2017-12-13 Tx date 2017-12-12 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-73,999.26
-33,333 vol $2.22 each |
1,787,000 | |
| Filed 2017-01-19 Tx date 2016-09-09 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+330,000 vol |
||
| Filed 2017-01-19 Tx date 2016-09-09 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
56 - Grant of rights
|
+330,000 vol |
330,000 | |
| Filed 2017-01-19 Tx date 2003-04-17 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-01-19 Tx date 2017-01-16 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$112,000
+400,000 vol $0.28 each |
1,820,333 | |
| Filed 2016-09-13 Tx date 2016-09-09 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+330,000 vol |
330,000 | |
| Filed 2016-09-13 Tx date 2003-04-17 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-12-02 Tx date 2015-12-01 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$308,280
+734,000 vol $0.42 each |
1,420,333 |